Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria-Reference-Cited by-同舟云学术

Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria

Published:2012-07 Issue:1 Volume:97 Page:91-98
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Fukumoto Shinya,Ishimura Eiji,Motoyama Koka,Morioka Tomoaki,Kimoto Eiji,Wakikawa Ken,Shoji Shigeichi,Koyama Hidenori,Shoji Tetsuo,Emoto Masanori,Nishizawa Yoshiki,Inaba Masaaki

Funder

Grant-in-Aid for Scientific Research

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference23 articles.

1. Standards of medical care in diabetes—2011;Diabetes Care,2011

2. Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels;Hansen;Circ Res,2001

3. Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm;Konda;Am J Nephrol,2009

4. A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker;Konoshita;J Hypertens,2010

5. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension;Kishi;Clin Exp Hypertens,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of cilnidipine-loaded self-micro-emulsifying drug delivery system (SMEDDS) by quantification of comparative pharmacokinetic parameters using validated LC-ESI-MS/MS bioanalytical method and pharmacodynamic assessment;Annales Pharmaceutiques Françaises;2024-07

2. A Comprehensive Insight on Pharmacological Properties of Cilnidipine: A Fourth-generation Calcium Channel Blocker;Cardiovascular & Hematological Agents in Medicinal Chemistry;2024-03

3. Newer Calcium Channel Blockers;Hypertension and Cardiovascular Disease in Asia;2022

4. Treatment of Hypertension Induced Albuminuria;Current Pharmaceutical Design;2019-02-27

5. Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients;Scientific Reports;2019-02-18